Atrial Fibrillation and Stroke in Cancer Patients

C. R. Manrique, J. C. Plana

Research output: Chapter in Book/Report/Conference proceedingChapter


Atrial fibrillation (AF) has a significant impact on our society. Currently, this disease is considered a growing epidemic in the world with an estimated 33.5 million cases worldwide in 2010, and the expectation for the number of cases to rise by at least 5% per year. In the same way, the number of patients with AF in the United States is expected to grow from 2.3 million in 2001 to 5.6-6.3 million in 2050. An epidemiological study conducted by Colilla et al. shows an incidence of 1.2 million cases in 2010, with a statistical projection to 2.6 million in 2030. Similar data have been reported in Europe with an estimated prevalence of AF in the general population of approximately 1.5-2% with an elevated economic cost for the healthcare systems. However, the dimension of the real problem could be underestimated in the light of subclinical disease.

Original languageEnglish (US)
Title of host publicationAnticancer Treatments and Cardiotoxicity
Subtitle of host publicationMechanisms, Diagnostic and Therapeutic Interventions
PublisherElsevier Inc.
Number of pages8
ISBN (Print)9780128025093
StatePublished - 2017


  • Atrial
  • Cancer
  • Fibrillation
  • Patients
  • Stroke

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Atrial Fibrillation and Stroke in Cancer Patients'. Together they form a unique fingerprint.

Cite this